Literature DB >> 16172737

The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis.

K Neiva1, Y-X Sun, R S Taichman.   

Abstract

Bone marrow stromal cells are critical regulators of hematopoiesis. Osteoblasts are part of the stromal cell support system in bone marrow and may be derived from a common precursor. Several studies suggested that osteoblasts regulate hematopoiesis, yet the entire mechanism is not understood. It is clear, however, that both hematopoietic precursors and osteoblasts interact for the production of osteoclasts and the activation of resorption. We observed that hematopoietic stem cells (HSCs) regulate osteoblastic secretion of various growth factors, and that osteoblasts express some soluble factors exclusively in the presence of HSCs. Osteoblasts and hematopoietic cells are closely associated with each other in the bone marrow, suggesting a reciprocal relationship between them to develop the HSC niche. One critical component regulating the niche is stromal-derived factor-1 (SDF-1) and its receptor CXCR4 which regulates stem cell homing and, as we have recently demonstrated, plays a crucial role in facilitating those tumors which metastasize to bone. Osteoblasts produce abundant amounts of SDF-1 and therefore osteoblasts play an important role in metastasis. These findings are discussed in the context of the role of osteoblasts in marrow function in health and disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172737     DOI: 10.1590/s0100-879x2005001000001

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  15 in total

1.  Processing of CXCL12 by different osteoblast-secreted cathepsins.

Authors:  Nicole D Staudt; Andreas Maurer; Bärbel Spring; Hubert Kalbacher; Wilhelm K Aicher; Gerd Klein
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 2.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 3.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 4.  The prostate cancer bone marrow niche: more than just 'fertile soil'.

Authors:  Elisabeth A Pedersen; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

Review 5.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.

Authors:  Xueqing Sun; Guangcun Cheng; Mingang Hao; Jianghua Zheng; Xiaoming Zhou; Jian Zhang; Russell S Taichman; Kenneth J Pienta; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 6.  Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.

Authors:  D Brooke Widner; Sun H Park; Matthew R Eber; Yusuke Shiozawa
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

7.  Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.

Authors:  Jenna E Fong; Damien Le Nihouannen; Svetlana V Komarova
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

8.  Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy.

Authors:  Kristen R Georgiou; Susanta K Hui; Cory J Xian
Journal:  Am J Stem Cells       Date:  2012-11-30

Review 9.  The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.

Authors:  Y Shiozawa; A M Havens; K J Pienta; R S Taichman
Journal:  Leukemia       Date:  2008-02-28       Impact factor: 11.528

10.  Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Peng-Yuan Zhuang; Ying Liang; Yun-Shan Tan; Jian He
Journal:  BMC Cancer       Date:  2009-06-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.